Autosomal Dominant Polycystic Kidney Disease
📧 Sign up to get email alerts when something new happens for Autosomal Dominant Polycystic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-19EMA Authorised: Jinarc (tolvaptan) — Otsuka Pharmaceutical Netherlands B.V.
Authorised status for Jinarc (tolvaptan) for polycystic kidney disease due to autosomal dominant inheritance, implemented by Otsuka Pharmace…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW) [Phase 2]
A Phase 2a trial of VX-407 in participants with autosomal dominant polycystic kidney disease who carry a subset of PKD1 gene variants; curre…
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease
A clinical trial update on PKD1 gene variant groups in autosomal dominant polycystic kidney disease, sponsored by Vertex, with the study cur…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: RADIOLOGICAL AND CLINICAL EVALUATION OF RENAL EMBOLIZATION USING EVOH IN DIALYSIS PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A PROSPECTIVE LONGITUDINAL OBSERVATIONAL STUDY
This prospective, longitudinal observational study assesses radiologic and clinical outcomes of renal embolization using Ethylene-vinyl alco…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate Homocysteine Metabolism and Endothelial Function in ADPKD
A Mayo Clinic study evaluating homocysteine metabolism and endothelial function in autosomal dominant polycystic kidney disease; currently a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Lanreotide In Polycystic Kidney Disease Study [Phase 3]
A Phase 3 clinical trial evaluating lanreotide for autosomal dominant polycystic kidney disease (ADPKD) has completed.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD) [Phase 3]
Ongoing Phase 3 trial IMPEDE-PKD is evaluating metformin therapy to slow the decline in kidney function for autosomal dominant polycystic ki…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Phase 1 Study Evaluating Safety, Tolerability, and Pharmacokinetics of VX-407 in Healthy Participants [Phase 1]
A Phase 1 clinical trial evaluating VX-407 for safety, tolerability, and pharmacokinetics in healthy participants has completed, with Autoso…
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: A Possible Founding PKD2 Mutation Associated With Variable Phenotypes of ADPKD in Bergamo Province
A completed clinical trial from the Mario Negri Institute reports a potential founder PKD2 mutation associated with variable phenotypes in A…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Developing a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare Diseases [NA]
This clinical trial update describes a project to develop RNA-Seq as a complementary diagnostic tool for rare diseases, with recruitment ong…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease [Phase 1]
Phase 1 clinical trial evaluating safety, tolerability, and pharmacokinetics of AZD1613 in adults with autosomal dominant polycystic kidney …
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Mass Balance and Absolute Bioavailability Study of JMKX003142 In Healthy Volunteers [Phase 1]
A Phase 1 mass-balance and absolute bioavailability study of the investigational drug JMKX003142 in healthy volunteers to characterize pharm…
-
CLINICAL_TRIALS research · 2026-03-06Clinical Trial Update: Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease [NA]
This clinical trial is recruiting to evaluate the metabolic effects of the Ren-Nu dietary program in autosomal dominant polycystic kidney di…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: STOP-PKD: SGLT2-inhibition to Improve Prognosis in Polycystic Kidney Disease [Phase 3]
Phase 3 STOP-PKD trial evaluating SGLT2 inhibitors to improve prognosis in autosomal dominant polycystic kidney disease. The study is curren…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Phase 1 Study to Evaluate the Safety and Tolerability of Intravenously Administered PYC-003 [Phase 1]
Phase 1 clinical trial evaluating the safety and tolerability of intravenously administered PYC-003 for autosomal dominant polycystic kidney…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life [Phase 3]
Phase 3 clinical trial evaluating hydrochlorothiazide to protect autosomal dominant polycystic kidney disease patients and improve quality o…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Safety of RotigotiNe in Patients With Autosomal Dominant Polycystic Kidney Disease [Phase 2]
A Phase 2 trial safety update for RotigotiNe in autosomal dominant polycystic kidney disease, with the study not yet recruiting.
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: A Study to Assess Adverse Events and Effectiveness of IntraVenous Infusions of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Phase 2]
This clinical trial update describes a Phase 2 study assessing the safety and effectiveness of intravenous ABBV-CLS-628 in adult participant…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Di-PKD: A Pilot Trial of Dietary Intervention in Patients With Autosomal Dominant Polycystic Kidney Disease [NA]
A pilot study (Di-PKD) is assessing a dietary intervention for Autosomal Dominant Polycystic Kidney Disease. The trial status is NOT_YET_REC…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Probenecid (PB) to Treat Hereditary Nephrogenic Diabetes Insipidus (NDI), ADPKD Treated With Tolvaptan, and Severely Polyuric Patients With Previous Lithium Administration [Phase 2]
Phase 2 clinical trial evaluating probenecid for hereditary nephrogenic diabetes insipidus, with autosomal dominant polycystic kidney diseas…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: A Prospective Observational Study of Foam Sclerotherapy .
This is a prospective observational clinical trial evaluating foam sclerotherapy for cyst-related manifestations in autosomal dominant polyc…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository
This study is a somatic mutation biorepository for Autosomal Dominant Polycystic Kidney Disease and is currently enrolling by invitation.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Robotic vs Open Nephrectomy for ADPKD
This clinical trials update concerns a study comparing robotic-assisted nephrectomy versus open nephrectomy in Autosomal Dominant Polycystic…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Intrarenal Microvasculature in ADPKD
A Mayo Clinic-sponsored study is investigating intrarenal microvasculature in autosomal dominant polycystic kidney disease. The study is cur…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Characterization of the Nrf2 Response in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This clinical trial update describes a study assessing the Nrf2 response in patients with autosomal dominant polycystic kidney disease and i…